Gender Differences in the Evaluation and Management of New Acute CHF Due to ATTRwt Cardiac Amyloidosis
- PMID: 38800288
- PMCID: PMC11128148
- DOI: 10.7759/cureus.59058
Gender Differences in the Evaluation and Management of New Acute CHF Due to ATTRwt Cardiac Amyloidosis
Abstract
Cardiac amyloidosis can be grouped into two main categories: immunoglobulin light chain (AL) and transthyretin (hATTR or hereditary and ATTRwt or wild type). Cardiac infiltration of misfolded proteins can lead to significant infiltrative processes and subsequent heart failure. Diagnosis of ATTRwt heavily relies on clinical suspicion, as it typically appears later in life and is limited to the heart. It is routinely reported that ATTRwt significantly affects males more than females; however, older patients diagnosed with ATTRwt and those diagnosed at autopsy are significantly more likely to be female. Earlier, a more precise diagnosis in females could detect disease at an earlier stage and expedite treatment.
Keywords: adult cardiac disease; amyloid; cardiac amyloid; gender differences; transthyretin amyloid cardiomyopathy.
Copyright © 2024, Fragner et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11128148/bin/cureus-0016-00000059058-i01.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11128148/bin/cureus-0016-00000059058-i02.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11128148/bin/cureus-0016-00000059058-i03.gif)
Similar articles
-
Hereditary Transthyretin Amyloidosis Cardiomyopathy: The South Florida Experience.Am J Cardiol. 2022 Oct 1;180:140-148. doi: 10.1016/j.amjcard.2022.06.048. Epub 2022 Aug 6. Am J Cardiol. 2022. PMID: 35945038
-
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).Cardiol Ther. 2022 Sep;11(3):393-405. doi: 10.1007/s40119-022-00265-7. Epub 2022 May 18. Cardiol Ther. 2022. PMID: 35583798 Free PMC article.
-
Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review.ESC Heart Fail. 2022 Jun;9(3):1524-1541. doi: 10.1002/ehf2.13884. Epub 2022 Mar 27. ESC Heart Fail. 2022. PMID: 35343098 Free PMC article. Review.
-
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.JACC CardioOncol. 2021 Oct 19;3(4):537-546. doi: 10.1016/j.jaccao.2021.08.009. eCollection 2021 Oct. JACC CardioOncol. 2021. PMID: 34729526 Free PMC article.
-
Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.J Thorac Dis. 2018 Mar;10(3):2034-2045. doi: 10.21037/jtd.2018.03.134. J Thorac Dis. 2018. PMID: 29707360 Free PMC article. Review.
References
-
- Estimating the gender distribution of patients with wild-type transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis. Kroi F, Fischer N, Gezin A, Hashim M, Rozenbaum MH. https://doi.org/10.1007/s40119-020-00205-3. Cardiol Ther. 2021;10:41–55. - PMC - PubMed
-
- Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis. Zampieri M, Argirò A, Allinovi M, et al. Int J Cardiol. 2022;351:71–77. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials